---
title: "AGIO.US (AGIO.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/AGIO.US/news.md"
symbol: "AGIO.US"
name: "AGIO.US"
parent: "https://longbridge.com/zh-HK/quote/AGIO.US.md"
datetime: "2026-03-13T17:10:06.025Z"
locales:
  - [en](https://longbridge.com/en/quote/AGIO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AGIO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AGIO.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/AGIO.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/AGIO.US/news.md)


# AGIO.US (AGIO.US) — 相關新聞

### [Insider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 2,959 Shares of Stock](https://longbridge.com/zh-HK/news/278446693.md)
*2026-03-09T20:57:00.000Z*
> Agios Pharmaceuticals insider Krishnan Viswanadhan sold 2,959 shares at $27.80 each, totaling $82,260.20, representing a

### [Zacks Research Analysts Lift Earnings Estimates for AGIO](https://longbridge.com/zh-HK/news/278329785.md)
*2026-03-09T05:10:56.000Z*
> Zacks Research analysts have raised their Q1 2026 earnings estimates for Agios Pharmaceuticals (NASDAQ:AGIO) from ($1.85

### [Weekly Buzz: TBPH Cuts Jobs, ASND Gets FDA Nod, AARD Puts HERO On Hold, ESPR Opens Wallet](https://longbridge.com/zh-HK/news/278125093.md)
*2026-03-06T14:54:00.000Z*
> The biotech sector experienced significant developments this week, including job cuts at Theravance Biopharma (TBPH) and

### [Top Agios Pharma Executive Makes Notable Insider Move With Recent Stock Sale](https://longbridge.com/zh-HK/news/278017602.md)
*2026-03-06T02:11:55.000Z*
> Agios Pharma's Chief Accounting Officer, Theodore James Jr. Washburn, sold 5,272 shares worth $152,255 on March 5, 2026,

### [Citigroup Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) Stock](https://longbridge.com/zh-HK/news/277981165.md)
*2026-03-05T19:58:25.000Z*
> Citigroup has raised its price target for Agios Pharmaceuticals (NASDAQ:AGIO) from $38.00 to $46.00, maintaining a "buy"

### [Agios Pharmaceuticals Teases 2026 Catalysts as PYRUKYND Thalassemia Launch Gains Early Traction](https://longbridge.com/zh-HK/news/277548017.md)
*2026-03-03T02:06:56.000Z*
> Agios Pharmaceuticals executives discussed upcoming clinical and regulatory milestones at the TD Cowen Healthcare Confer

### [Agios Pharmaceuticals Says Pyrukynd Thalassemia Treatment Approved by UAE Drug Regulator](https://longbridge.com/zh-HK/news/277478194.md)
*2026-03-02T13:43:00.000Z*
> Agios Pharmaceuticals announced that the UAE Drug Establishment has approved Pyrukynd for treating adult patients with b

### [Agios Pharma's PYRUKYND Approved In UAE For Alpha- And Beta-Thalassemia](https://longbridge.com/zh-HK/news/277470109.md)
*2026-03-02T13:10:43.000Z*
> Agios Pharmaceuticals, Inc. announced that the Emirates Drug Establishment has approved PYRUKYND (mitapivat) for treatin